VYGR

1.5304.97%
AQ

Amy Quinlan

Principal Accounting Officer

Ms. Amy Quinlan is Principal Accounting Officer of Voyager Therapeutics, Inc. from May 8, 2026 and served as the Vice President of Finance since January 2025 until May 8, 2026. Ms. Quinlan was Interim Principal Accounting Officer of Vor Biopharma Inc. from June 21, 2024. She was Vice President of Finance at Vor Biopharma Inc since September 2020. Prior to that, Ms. Quinlan served as Vice President and Controller at TetraPhase Pharmaceuticals Inc. from 2008 to August 2020. Ms. Quinlan received her Bachelor of Science in Financial Accounting from Bryant University.

Positions